Modulation of T-cell function by type i interferon

Immunology and Cell Biology

Volumn 90, Issue 5, 2012, Pages 492-497

  Tough, David F ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

apoptosis; cytotoxic T cell; T cells; Th1; type I interferon

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 21; INTERLEUKIN 5; T LYMPHOCYTE RECEPTOR;

ANTIGEN SPECIFICITY; CELL DIFFERENTIATION; CELL DIVISION; CELL EXPANSION; CELL MIGRATION; CELL PROLIFERATION; CELL STIMULATION; CELL SURVIVAL; EFFECTOR CELL; EXPERIMENTAL MODEL; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE FUNCTION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MEMORY CELL; MOUSE STRAIN; NONHUMAN; PROTEIN EXPRESSION; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ADAPTIVE IMMUNITY; ANIMALS; CELLULAR MICROENVIRONMENT; HUMANS; IMMUNITY, INNATE; INTERFERON TYPE I; RECEPTOR CROSS-TALK; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; VIRUS DISEASES;

EID: 84861709318     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2012.7     Document Type: Review

References (69)

1. Pestka S, Krause CD, Walter MR. Interferons, interferon-like cytokines, and their receptors. Immunol Rev 2004; 202: 8-32.
2. Isaacs A, Lindenmann J. Virus interference. 1. The interferon. Proc R Soc Lond B: Biol Sci 1957; 147: 258-273.
3. Gresser I, Tovey MG, Bandu ME, Maury C, Brouty-Boye D. Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. I. Rapid evolution of encephalomyocarditis virus infection. J Exp Med 1976; 144: 1305-1315.
4. Gresser I, Tovey MG, Maury C, Bandu MT. Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. II. Studies with herpes simplex, Moloney sarcoma, vesicular stomatitis, Newcastle disease, and influenza viruses. J Exp Med 1976; 144: 1316-1323.
5. Muller U, Steinhoff U, Reis LF, Hemmi S, Pavlovic J, Zinkernagel RM et al. Functional role of type I and type II interferons in antiviral defense. Science 1994; 264: 1918-1921.
6. Fensterl V, Sen GC. Interferons and viral infections. BioFactors 2009; 35: 14-20.
7. Trinchieri G, Santoli D. Anti-viral activity induced by culturing lymphocytes with tumorderived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis. J ExpMed 1978; 147: 1314-1333.
8. Goodbourn S, Didcock L, Randall RE. Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J Gen Virol 2000; 81: 2341-2364.
9. Siegal FP, Kadowaki N, Shodell M, Fitzgerald-Bocarsly PA, Shah K, Ho S et al. The Nature of the Principal Type 1 Interferon-Producing Cells in Human Blood. Science 1999; 284: 1835-1837.
10. Fitzgerald-Bocarsly P. Human natural interferon-alpha producing cells. Pharmacol Ther 1993; 60: 39-62.
11. Tough DF. Type I interferon as a link between innate and adaptive immunity through dendritic cell stimulation. Leuk Lymphoma 2004; 45: 257-264.
12. Gallucci S, Lolkema M, Matzinger P. Natural adjuvants: Endogenous activators of dendritic cells. Nat Med 1999; 5: 1249-1255.
13. Proietti E, Bracci L, Puzelli S, Di Pucchio T, Sestili P, De Vincenzi E et al. Type I IFN as a natural adjuvant for a protective immune response: Lessons from the influenza vaccine model. J Immunol 2002; 169: 375-383.
14. Le Bon A, Etchart N, Rossmann C, Ashton M, Hou S, Gewert D et al. Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon. Nat Immunol 2003; 4: 1009-1015.
15. Le Bon A, Schiavoni G, D'Agostino G, Gresser I, Belardelli F, Tough DF. Type I interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity 2001; 14: 461-470.
16. Uden JHV, Tran CH, Carson DA, Raz E. Type I interferon is required to mount an adaptive response to immunostimulatory DNA. Eur J Immunol 2001; 31: 3281-3290.
17. Hervas-Stubbs S, Perez-Gracia JL, Rouzaut A, Sanmamed MF, Le Bon A, Melero I. Direct Effects of Type I Interferons on Cells of the Immune System. Clin Cancer Res 2011; 17: 2619-2627.
18. Le Bon A, Thompson C, Kamphuis E, Durand V, Rossmann C, Kalinke U et al. Cutting Edge: Enhancement of antibody responses through direct stimulation of B and T cells by type I IFN. J Immunol 2006; 176: 2074-2078.
19. Shiow LR, Rosen DB, Brdickova N, Xu Y, An J, Lanier LL et al. CD69 acts downstream of interferon-[alpha]/[beta] to inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature 2006; 440: 540-544.
20. Asselin-Paturel C, Brizard Gr, Chemin K, Boonstra A, O'Garra A, Vicari A et al. Type I interferon dependence of plasmacytoid dendritic cell activation and migration. J Exp Med 2005; 201: 1157-1167.
21. Parlato S, Santini SM, Lapenta C, Di Pucchio T, Logozzi M, Spada M et al. Expression of CCR-7, MIP-3b, and Th-1 chemokines in type I IFN-induced monocyte-derived dendritic cells: importance for the rapid acquisition of potent migratory and functional activities. Blood 2001; 98: 3022-3029.
22. Luft T, Pang KC, Thomas E, Hertzog P, Hart DNJ, Trapani J et al. Type I IFNs enhance the terminal differentiation of dendritic cells. J Immunol 1998; 161: 1947-1953.
23. Wang JH, Li J, Wu Q, Yang P, Pawar RD, Xie S et al. Marginal zone precursor B cells as cellular agents for type I IFN-promoted antigen transport in autoimmunity. J Immunol 2010; 184: 442-451.
24. Zhang X, Sun S, Hwang I, Tough DF, Sprent J. Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. Immunity 1998; 8: 591-599.
25. Havenar-Daughton C, Kolumam GA, Murali-Krishna K. Cutting Edge: The direct action of type I IFN on CD4 T cells is critical for sustaining clonal expansion in response to a viral but not a bacterial infection. J Immunol 2006; 176: 3315-3319.
26. Kolumam GA, Thomas S, Thompson LJ, Sprent J, Murali-Krishna K. Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J Exp Med 2005; 202: 637-650.
27. Aichele P, Unsoeld H, Koschella M, Schweier O, Kalinke U, Vucikuja S. Cutting Edge: CD8 T cells specific for lymphocytic choriomeningitis virus require type I IFN receptor for clonal expansion. J Immunol 2006; 176: 4525-4529.
28. Merigan TC, Oldstone MBA, Welsh RM. Interferon production during lymphocytic choriomeningitis virus infection of nude and normal mice. Nature 1977; 268: 67-68.
29. Le Bon A, Durand V, Kamphuis E, Thompson C, Bulfone-Paus S, Rossmann C et al. Direct stimulation of T cells by type I IFN enhances the CD8+ T cell response during cross-priming. J Immunol 2006; 176: 4682-4689.
30. Gu H, Zou Y-R, Rajewsky K. Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting. Cell 1993; 73: 1155-1164.
31. Wiesel M, Crouse J, Bedenikovic G, Sutherland A, Joller N, Oxenius A. Type-I IFN drives the differentiation of short-lived effector CD8+ T cells in vivo. Eur J Immunol 2011; 42: 320-329.
32. Wiesel M, Kratky W, Oxenius A. Type I IFN substitutes for T cell help during viral infections. J Immunol 2011; 186: 754-763.
33. Curtsinger JM, Valenzuela JO, Agarwal P, Lins D, Mescher MF. Cutting Edge: Type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation. J Immunol 2005; 174: 4465-4469.
34. Hervas-Stubbs S, Riezu-Boj J-I, Gonzalez I, Manchenõ U, Dubrot J, Azpilicueta A et al. Effects of IFN-α as a signal-3 cytokine on human naïve and antigen-experienced CD8+ T cells. Eur J Immunol 2010; 40: 3389-3402.
35. Marrack P, Kappler J, Mitchell T. Type I interferons keep activated T cells alive. J Exp Med 1999; 189: 521-530.
36. Pilling D, Akbar AN, Girdlestone J, Orteu CH, Borthwick NJ, Amft N et al. Interferon-b mediates stromal cell rescue of T cells from apoptosis. Eur J Immunol 1999; 29: 1041-1050.
37. Kaser A, Nagata S, Tilg H. Interferon alpha augments activation-induced T cell death by upregulation of Fas (CD95/APO-1) and Fas ligand expression. Cytokine 1999; 11: 736-743.
38. Terawaki S, Chikuma S, Shibayama S, Hayashi T, Yoshida T, Okazaki T et al. IFN-α directly promotes programmed cell death-1 transcription and limits the duration of T cell-mediated immunity. J Immunol 2011; 186: 2772-2779.
39. Lindahl-Magnusson P, Leary P, Gresser I. Interferon inhibits DNA synthesis induced in mouse lymphocyte suspensions by phytohaemagglutinin or allogeneic cells. Nat New Biol 1972; 237: 120-121.
40. Petricoin EF, Ito S, Williams BL, Audet S, Stancato LF, Gamero A et al. Antiproliferative action of interferon-A requires components of T-cell-receptor signalling. Nature 1997; 390: 629-632.
41. Sun S, Zhang X, Tough DF, Sprent J. Type I interferon-mediated stimulation of T cells by CpG DNA. J Exp Med 1998; 188: 2335-2342.
42. Zella D, Romerio F, Curreli S, Secchiero P, Cicala C, Zagury D et al. IFN-α2b reduces IL-2 production and IL-2 receptor function in primary CD4+ T cells. J Immunol 2000; 164: 2296-2302.
43. Feng H, Zhang D, Palliser D, Zhu P, Cai S, Schlesinger A et al. Listeria-infected myeloid dendritic cells produce IFN-β, priming T Cell activation. J Immunol 2005; 175: 421-432.
44. Avraamides G, Ng C-Y, David R, Gu Y, Fazekasova H, Mirenda V et al. IFN-α2 induces leukocyte integrin redistribution, increased adhesion, and migration. J Interferon Cytokine Res 2007; 27: 291-304.
45. Dondi E, Rogge L, Lutfalla G, Uze G, Pellegrini S. Down-modulation of responses to type I IFN upon T cell activation. J Immunol 2003; 170: 749-756.
46. Matikainen S, Sareneva T, Ronni T, Lehtonen A, Koskinen PiJ, Julkunen I. Interferon-a activates multiple STAT proteins and upregulates proliferation-associated IL-2Ra, c-myc, and pim-1 genes in human T cells. Blood 1999; 93: 1980-1991.
47. Gil MP, Salomon R, Louten J, Biron CA. Modulation of STAT1 protein levels: a mechanism shaping CD8 T-cell responses in vivo. Blood 2006; 107: 987-993.
48. Stark GR, Kerr IM, Williams BRG, Silverman RH, Schreiber RD. How cells respond to interferons. Annu Rev Biochem 1998; 67: 227-264.
49. Bromberg JF, Horvath CM, Wen Z, Schreiber RD, Darnell JE. Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma. Proc Natl Acad Sci 1996; 93: 7673-7678.
50. Tanabe Y, Nishibori T, Su L, Arduini RM, Baker DP, David M. Cutting Edge: Role of STAT1, STAT3, and STAT5 in IFN-αb responses in T lymphocytes. J Immunol 2005; 174: 609-613.
51. Marshall HD, Urban SL, Welsh RM. Virus-induced transient immune suppression and the inhibition of T cell proliferation by type I interferon. J Virol 2011; 85: 5929-5939.
52. Agarwal P, Raghavan A, Nandiwada SL, Curtsinger JM, Bohjanen PR, Mueller DL et al. Gene regulation and chromatin remodeling by IL-12 and type I IFN in programming for CD8 T cell effector function and memory. J Immunol 2009; 183: 1695-1704.
53. Persky ME, Murphy KM, Farrar JD. IL-12, but not IFN-α, promotes STAT4 activation and Th1 development in murine CD4+ T cells expressing a chimeric murine/human Stat2 gene. J Immunol 2005; 174: 294-301.
54. Athie-Morales V, Smits HH, Cantrell DA, Hilkens CMU. Sustained IL-12 signaling Is required for Th1 development. J Immunol 2004; 172: 61-69.
55. Shibuya H, Nagai T, Ishii A, Yamamoto K, Hirohata S. Differential regulation of Th1 responses and CD154 expression in human CD4+ T cells by IFN-α. Clin Exp Immunol 2003; 132: 216-224.
56. Sareneva T, Julkunen I, Matikainen S. IFN-α and IL-12 induce IL-18 receptor gene expression in human NK and T cells. J Immunol 2000; 165: 1933-1938.
57. Strengell M, Julkunen I, Matikainen S. IFN-α regulates IL-21 and IL-21R expression in human NK and T cells. J Leukoc Biol 2004; 76: 416-422.
58. Crotty S. Follicular Helper CD4 T Cells (TFH). Annu Rev Immunol 2011; 29: 621-663.
59. Strengell M, Matikainen S, Siren J, Lehtonen A, Foster D, Julkunen I et al. IL-21 in synergy with IL-15 or IL-18 enhances IFN-g production in human NK and T cells. J Immunol 2003; 170: 5464-5469.
60. Huber JP, Ramos HJ, Gill MA, Farrar JD. Cutting Edge: Type I IFN reverses human Th2 commitment and stability by suppressing GATA3. J Immunol 2010; 185: 813-817.
61. Schandene L, Del Prete GF, Cogan E, Stordeur P, Crusiaux A, Kennes B et al. Recombinant interferon-alpha selectively inhibits the production of interleukin-5 by human CD4+ T cells. J Clin Invest 1996; 97: 309-315.
62. Shibuya H, Hirohata S. Differential effects of IFN-α on the expression of various TH2 cytokines in human CD4+ T cells. J Allergy Clin Immunol 2005; 116: 205-212.
63. Eriksen KW, Sommer VH, Woetmann A, Rasmussen AB, Brender C, Svejgaard A et al. Bi-phasic Effect of Interferon (IFN)-a. IFN-α up-and down-regulates Iinterleukin-4 signaling in human T cells. J Biol Chem 2004; 279: 169-176.
64. Moschen AR, Geiger S, Krehan I, Kaser A, Tilg H. Interferon-alpha controls IL-17 expression in vitro and in vivo. Immunobiology 2008; 213: 779-787.
65. Pepper M, Jenkins MK. Origins of CD4+ effector and central memory T cells. Nat Immunol 2011; 12: 467-471.
66. Xiao Z, Casey KA, Jameson SC, Curtsinger JM, Mescher MF. Programming for CD8 T cell memory development requires IL-12 or type I IFN. J Immunol 2009; 182: 2786-2794.
67. Davis AM, Ramos HJ, Davis LS, Farrar JD. Cutting Edge: A T-bet-independent role for IFN-α/b in regulating IL-2 secretion in human CD4+ central memory T cells. J Immunol 2008; 181: 8204-8208.
68. Thompson LJ, Kolumam GA, Thomas S, Murali-Krishna K. Innate inflammatory signals induced by various pathogens differentially dictate the IFN-I dependence of CD8 T cells for clonal expansion and memory formation. J Immunol 2006; 177: 1746-1754.
69. Cousens LP, Orange JS, Su HCS, Biron CA. Interferon-a/b inhibition of interleukin 12 and interferon-g production in vitro and endogenously during viral infection. Proc Natl Acad Sci 1997; 94: 634-639.